Back to News

Introducing the WelchAllyn RetinaVue

February 11, 2018

Now you can easily and accurately screen for diabetic retinopathy using a SIMPLE and EFFECTIVE four-step process right at the point-of-care. The WelchAllyn RetinaVue Network is designed for healthcare providers who want to improve management of their patients with diabetes.

  • Acquire - Acquire non-mydriatic fundus images in minutes with the simple, automated Welch Allyn RetinaVue 100 Imager
  • Transfer - Encrypted images sent via secure HIPAA-compliant RetinaVue Network
  • Analyze - Images are evaluated by a board-certified retinal specialist
  • Report - Diagnostic report and referral/screening plan returned the same day —usually in 90 minutes

Patient compliance rates can double in 12 months!

For more information, click here. Or contact your Account Representative for a demo!